Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in TVTX / Travere Therapeutics, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 15,008 shares of Travere Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (TVTX) in the form of stock options. The firm currently holds call options representing 120,000 of underlying shares valued at $4,585,200 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TVTX / Travere Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 0 -15,008 -100.00 0 -100.00
2025-11-12 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 15,008 15,008 359 0.0006
2025-08-14 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 0 -12,369 -100.00 0 -100.00
2025-05-14 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 12,369 -4,141 -25.08 222 -23.00 0.0006
2025-05-14 2024-12-31 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 16,510 -903 -5.19 288 18.11 0.0007
2025-02-14 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 16,510 -903 288 0.0007
2024-11-14 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 17,413 -19,351 -52.64 244 -19.54 0.0007
2024-08-14 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 36,764 28,829 363.31 302 395.08 0.0012
2024-05-10 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 7,935 7,935 61 0.0002
2023-11-09 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 0 -14,951 -100.00 0 -100.00
2023-08-09 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 14,951 14,951 230 0.0007
2022-02-11 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 0 -1,701 -100.00 0 -100.00
2021-11-12 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 1,701 -3,662 -68.28 41 -47.44 0.0000
2021-08-10 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 5,363 5,307 9,476.79 78 7,700.00 0.0001
2021-05-12 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 56 -2,206 -97.52 1 -98.39 0.0000
2021-02-10 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 2,262 2,262 62 0.0001
2020-08-13 2020-06-30 13F RETROPHIN COM 761299106 0 -753 -100.00 0 -100.00
2020-05-13 2020-03-31 13F RETROPHIN COM 761299106 753 -39 -4.92 11 0.00 0.0001
2020-02-10 2019-12-31 13F RETROPHIN COM 761299106 792 -196 -19.84 11 0.00 0.0001
2019-11-12 2019-09-30 13F RETROPHIN COM 761299106 988 -23,499 -95.97 11 -97.76 0.0001
2019-08-09 2019-06-30 13F RETROPHIN COM 761299106 24,487 24,487 492 0.0045
2018-08-13 2018-06-30 13F RETROPHIN COM 761299106 0 -68 -100.00 0 -100.00
2018-05-16 2018-03-31 13F/A-1 RETROPHIN COM 761299106 68 0 0.00 2 100.00 0.0000
2018-05-10 2018-03-31 13F RETROPHIN COM 761299106 68 0 2
2018-02-09 2017-12-31 13F RETROPHIN COM 761299106 68 -1,499 -95.66 1 -96.55 0.0000
2017-05-10 2017-03-31 13F RETROPHIN COM 761299106 1,567 338 27.50 29 26.09 0.0003
2017-02-15 2016-12-31 13F RETROPHIN COM 761299106 1,229 1,229 23 0.0002
2016-11-14 2016-09-30 13F RETROPHIN COM 761299106 0 -41,659 -100.00 0 -100.00
2016-08-12 2016-06-30 13F RETROPHIN COM 761299106 41,659 -47,044 -53.04 742 -38.78 0.0088
2016-05-12 2016-03-31 13F RETROPHIN COM 761299106 88,703 63,828 256.59 1,212 152.50 0.0171
2016-02-11 2015-12-31 13F RETROPHIN COM 761299106 24,875 7,723 45.03 480 37.93 0.0057
2015-11-20 2015-09-30 13F/A-1 RETROPHIN COM 761299106 17,152 15,796 1,164.90 348 673.33 0.0048
2015-11-06 2015-09-30 13F RETROPHIN COM 761299106 17,152 348
2015-08-11 2015-06-30 13F RETROPHIN COM 761299106 1,356 -30,045 -95.68 45 -94.02 0.0006
2015-05-14 2015-03-31 13F RETROPHIN COM 761299106 31,401 28,232 890.88 752 1,828.21 0.0118
2015-02-11 2014-12-31 13F RETROPHIN COM 761299106 3,169 1,446 83.92 39 143.75 0.0006
2014-10-31 2014-09-30 13F RETROPHIN COM 761299106 1,723 -19,497 -91.88 16 -93.57 0.0002
2014-08-12 2014-06-30 13F RETROPHIN COM 761299106 21,220 21,220 249 0.0038
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F TRAVERE THERAPEUTICS COM Call 120,000 113.90 4,585 242.16 n/a n/a n/a
2025-11-12 2025-09-30 13F TRAVERE THERAPEUTICS COM Call 56,100 -77.74 1,341 -64.07 n/a n/a n/a
2025-08-14 2025-06-30 13F TRAVERE THERAPEUTICS COM Call 252,000 69.47 3,730 39.98 n/a n/a n/a
2025-05-14 2025-03-31 13F TRAVERE THERAPEUTICS COM Call 148,700 249.06 2,665 259.03 n/a n/a n/a
2025-05-14 2024-12-31 13F/A TRAVERE THERAPEUTICS COM Call 42,600 -22.12 742 -3.01 n/a n/a n/a
2025-02-14 2024-12-31 13F TRAVERE THERAPEUTICS COM Call 42,600 742 n/a n/a n/a
2024-11-14 2024-09-30 13F TRAVERE THERAPEUTICS COM Call 54,700 43.57 765 144.41 n/a n/a n/a
2024-08-14 2024-06-30 13F TRAVERE THERAPEUTICS COM Call 38,100 -14.96 313 -9.28 n/a n/a n/a
2024-05-10 2024-03-31 13F TRAVERE THERAPEUTICS COM Call 44,800 -60.25 345 -65.94 n/a n/a n/a
2024-02-14 2023-12-31 13F TRAVERE THERAPEUTICS COM Call 112,700 -44.29 1,013 -43.97 n/a n/a n/a
2023-11-09 2023-09-30 13F TRAVERE THERAPEUTICS COM Call 202,300 2,460.76 1,809 1,394.21 n/a n/a n/a
2023-08-09 2023-06-30 13F TRAVERE THERAPEUTICS COM Call 7,900 29.51 121 -11.68 n/a n/a n/a
2023-05-12 2023-03-31 13F TRAVERE THERAPEUTICS COM Call 6,100 -59.33 137 -56.51 n/a n/a n/a
2023-02-09 2022-12-31 13F TRAVERE THERAPEUTICS COM Call 15,000 0.00 315 -14.86 n/a n/a n/a
2022-11-09 2022-09-30 13F TRAVERE THERAPEUTICS COM Call 15,000 -9.09 370 -7.50 n/a n/a n/a
2022-08-11 2022-06-30 13F TRAVERE THERAPEUTICS COM Call 16,500 3.12 400 -2.91 n/a n/a n/a
2022-05-12 2022-03-31 13F TRAVERE THERAPEUTICS COM Call 16,000 25.98 412 4.57 n/a n/a n/a
2022-02-11 2021-12-31 13F TRAVERE THERAPEUTICS COM Call 12,700 217.50 394 306.19 n/a n/a n/a
2021-11-12 2021-09-30 13F TRAVERE THERAPEUTICS COM Call 4,000 110.53 97 246.43 n/a n/a n/a
2021-08-10 2021-06-30 13F TRAVERE THERAPEUTICS COM Call 1,900 850.00 28 460.00 n/a n/a n/a
2021-05-12 2021-03-31 13F TRAVERE THERAPEUTICS COM Call 200 5 n/a n/a n/a
2021-02-10 2020-12-31 13F RETROPHIN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-12 2020-09-30 13F RETROPHIN COM Call 10,000 185 n/a n/a n/a
2020-05-12 2020-03-31 13F RETROPHIN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-10 2019-12-31 13F RETROPHIN COM Call 10,000 -72.53 142 -66.35 n/a n/a n/a
2019-11-12 2019-09-30 13F RETROPHIN COM Call 36,400 422 n/a n/a n/a
2019-08-09 2019-06-30 13F RETROPHIN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-14 2019-03-31 13F/A RETROPHIN COM Call 1,000 23 n/a n/a n/a
2019-05-13 2019-03-31 13F RETROPHIN COM Call 1,000 23 n/a n/a n/a
2019-02-05 2018-12-31 13F RETROPHIN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-08 2018-09-30 13F RETROPHIN COM Call 9,700 279 n/a n/a n/a
2018-05-16 2018-03-31 13F/A RETROPHIN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-09 2017-12-31 13F RETROPHIN COM Call 12,500 4.17 263 -12.04 n/a n/a n/a
2017-11-15 2017-09-30 13F RETROPHIN COM Call 12,000 900.00 299 1,200.00 n/a n/a n/a
2017-08-14 2017-06-30 13F RETROPHIN COM Call 1,200 100.00 23 109.09 n/a n/a n/a
2017-05-10 2017-03-31 13F RETROPHIN COM Call 600 -96.43 11 -96.54 n/a n/a n/a
2017-02-15 2016-12-31 13F RETROPHIN COM Call 16,800 -50.44 318 -58.10 n/a n/a n/a
2016-11-14 2016-09-30 13F RETROPHIN COM Call 33,900 156.82 759 222.98 n/a n/a n/a
2016-08-12 2016-06-30 13F RETROPHIN COM Call 13,200 17.86 235 53.59 n/a n/a n/a
2016-05-12 2016-03-31 13F RETROPHIN COM Call 11,200 -85.42 153 -89.67 n/a n/a n/a
2016-02-11 2015-12-31 13F RETROPHIN COM Call 76,800 -8.13 1,481 -12.57 n/a n/a n/a
2015-11-20 2015-09-30 13F/A RETROPHIN COM Call 83,600 207.35 1,694 87.80 n/a n/a n/a
2015-11-06 2015-09-30 13F RETROPHIN COM Call 83,600 1,694 n/a n/a n/a
2015-08-11 2015-06-30 13F RETROPHIN COM Call 27,200 -28.80 902 -1.42 n/a n/a n/a
2015-05-14 2015-03-31 13F RETROPHIN COM Call 38,200 213.11 915 514.09 n/a n/a n/a
2015-02-11 2014-12-31 13F RETROPHIN COM Call 12,200 -9.63 149 22.13 n/a n/a n/a
2014-10-31 2014-09-30 13F RETROPHIN COM Call 13,500 -25.41 122 -42.45 n/a n/a n/a
2014-08-12 2014-06-30 13F RETROPHIN COM Call 18,100 212 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-11-12 2020-09-30 13F RETROPHIN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-13 2020-06-30 13F RETROPHIN COM Put 13,000 265 n/a n/a n/a
2020-05-12 2020-03-31 13F RETROPHIN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-10 2019-12-31 13F RETROPHIN COM Put 5,300 -36.14 75 -21.87 n/a n/a n/a
2019-11-12 2019-09-30 13F RETROPHIN COM Put 8,300 -83.69 96 -90.62 n/a n/a n/a
2019-08-09 2019-06-30 13F RETROPHIN COM Put 50,900 -7.45 1,023 -17.83 n/a n/a n/a
2019-05-14 2019-03-31 13F/A RETROPHIN COM Put 55,000 54,900.00 1,245 5,313.04 n/a n/a n/a
2019-05-13 2019-03-31 13F RETROPHIN COM Put 55,000 1,245 n/a n/a n/a
2019-02-05 2018-12-31 13F RETROPHIN COM Put 100 -50.00 23 283.33 n/a n/a n/a
2018-11-08 2018-09-30 13F RETROPHIN COM Put 200 100.00 6 100.00 n/a n/a n/a
2018-08-13 2018-06-30 13F RETROPHIN COM Put 100 0.00 3 50.00 n/a n/a n/a
2018-05-16 2018-03-31 13F/A RETROPHIN COM Put 100 0.00 2 0.00 n/a n/a n/a
2018-05-10 2018-03-31 13F RETROPHIN COM Put 100 2 n/a n/a n/a
2018-02-09 2017-12-31 13F RETROPHIN COM Put 100 -95.24 2 -96.15 n/a n/a n/a
2017-11-15 2017-09-30 13F RETROPHIN COM Put 2,100 2,000.00 52 2,500.00 n/a n/a n/a
2017-08-14 2017-06-30 13F RETROPHIN COM Put 100 -96.15 2 -95.83 n/a n/a n/a
2017-05-10 2017-03-31 13F RETROPHIN COM Put 2,600 -7.14 48 -9.43 n/a n/a n/a
2017-02-15 2016-12-31 13F RETROPHIN COM Put 2,800 -95.86 53 -96.50 n/a n/a n/a
2016-11-14 2016-09-30 13F RETROPHIN COM Put 67,600 -17.96 1,513 3.07 n/a n/a n/a
2016-08-12 2016-06-30 13F RETROPHIN COM Put 82,400 -63.28 1,468 -52.10 n/a n/a n/a
2016-05-12 2016-03-31 13F RETROPHIN COM Put 224,400 110.90 3,065 49.37 n/a n/a n/a
2016-02-11 2015-12-31 13F RETROPHIN COM Put 106,400 98.88 2,052 89.30 n/a n/a n/a
2015-11-20 2015-09-30 13F/A RETROPHIN COM Put 53,500 1,683.33 1,084 994.95 n/a n/a n/a
2015-11-06 2015-09-30 13F RETROPHIN COM Put 53,500 1,084 n/a n/a n/a
2015-08-11 2015-06-30 13F RETROPHIN COM Put 3,000 -91.38 99 -88.13 n/a n/a n/a
2015-05-14 2015-03-31 13F RETROPHIN COM Put 34,800 834 n/a n/a n/a
2015-02-11 2014-12-31 13F RETROPHIN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-10-31 2014-09-30 13F RETROPHIN COM Put 9,300 -69.21 84 -76.34 n/a n/a n/a
2014-08-12 2014-06-30 13F RETROPHIN COM Put 30,200 355 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.